Clal Insurance Enterprises Holdings LTD Amgen Inc Transaction History

Clal Insurance Enterprises Holdings LTD

  • $11.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023
SELL
$214.27 - $253.37 $428,540 - $506,740
-2,000 Reduced 40.0%
3,000 $666,000
Q1 2023

May 09, 2023
BUY
$225.79 - $275.2 $1.13 Million - $1.38 Million
5,000 New
5,000 $1.21 Million
Q2 2022

Aug 09, 2022
SELL
$230.71 - $256.74 $461,420 - $513,480
-2,000 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$219.27 - $242.57 $438,540 - $485,140
2,000 New
2,000 $484,000

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Clal Insurance Enterprises Holdings LTD Portfolio

Follow Clal Insurance Enterprises Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email